✦ LIBER ✦

Computational studies of the binding site of α1A-adrenoceptor antagonists

✍ Scribed by Minyong Li; Hao Fang; Lupei Du; Lin Xia; Binghe Wang

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 658 KB
Volume: 14
Category: Article
ISSN: 1610-2940
DOI: 10.1007/s00894-008-0342-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Structure-Activity Relationship Studies

Structure-Activity Relationship Studies of a Number of α1-Adrenoceptor Antagonists and Antiarrhythmic Agents

✍ Alicja Nowaczyk; Rafał Przybylski; Katarzyna Kulig; Barbara Malawska 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 476 KB

Arylpiperazines represent one of the most studied classes of α1 -adrenoceptor (α1 -AR) antagonists. Currently, α1 -AR antagonists are useful in the treatment of benign prostatic hyperplasia, lower urinary tract symptoms or cardiac arrhythmia. The activity of various derivatives of 1-[3-(4-arylpipera

Computational studies of the binding mod

Computational studies of the binding modes of A2Aadenosine receptor antagonists

✍ Y. Ye; J. Wei; X. Dai; Q. Gao 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 450 KB

Molecular modeling of a putative antagon

Molecular modeling of a putative antagonist binding site on helix III of the β-adrenoceptor

✍ H. W. Th. van Vlijmen; A. P. Ijzerman 📂 Article 📅 1989 🏛 Springer Netherlands 🌐 English ⚖ 604 KB

Absolute Configuration of the α1B-Adreno

Absolute Configuration of the α1B-Adrenoceptor Antagonist (+)-Cyclazosin.

✍ Dario Giardina; Gianni Sagratini; Massimo Grelli; Ugo Gulini; Carlo Melchiorre; 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 12 KB 👁 1 views

3D-QSAR study on phenoxyalkylamine compo

3D-QSAR study on phenoxyalkylamine compounds of α1-adrenoceptor antagonist

✍ Hao Fang; Jingfen Lu; Lin Xia; Line Zhang 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 449 KB

Pharmacological characterization of A-13

Pharmacological characterization of A-131701, a novel α1-adrenoceptor antagonist selective for α1A- and α1D-compared to α1B-adrenoceptors

✍ Arthur A. Hancock; Steven A. Buckner; Michael E. Brune; Sweta Katwala; Ivan Mili 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 1 views

New compounds selective for α 1A -adrenoceptors in the prostate may offer enhanced efficacy for benign prostatic hyperplasia (BPH), with fewer side effects than current treatment. A-131701 (3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b,hexahydro-[1H]-benz[e]isoindol-2-yl)ethyl]pyrido[3′,4′:4,5]thieno